Patents by Inventor Qiu Zhong

Qiu Zhong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230160799
    Abstract: A molten-state suspended ellipsoidal droplet image processing algorithm is based on dual-camera vision. The algorithm includes acquiring images of a standard sphere by means of two cameras, and calculating the actual size corresponding to each individual pixel of the two standard sphere images; synchronously acquiring two images of a droplet by using the two cameras at a specified included angle; establishing an ellipsoidal quadric surface equation for the droplet, respectively detecting edge contour lines of the two images, and establishing elliptical contour line equations for the edge contour lines; introducing a specified included angle, and constructing an equation set according to relationships between parameters of the two elliptical contour line equations and the ellipsoidal quadric surface equation; solving the equation set to obtain the length of each semi-axis of the droplet; and calculating the volume of the droplet according to the length of each semi-axis.
    Type: Application
    Filed: April 9, 2021
    Publication date: May 25, 2023
    Inventors: Liping YANG, Qiu ZHONG, Huidong LI, Ye TAO
  • Publication number: 20220148212
    Abstract: Disclosed is a method for measuring surface tension based on an axisymmetric droplet contour curve. The method comprises: photographing a suspended droplet image, and extracting a droplet contour curve; selecting a measurement point on the droplet contour curve; and calculating the surface tension of a liquid using the following formula ? = ?? ? ? gV + P ? ? ? ? ? R 2 2 ? ? ? ? R ? ? sin ? ( ? ) , wherein ? is the surface tension of the liquid, ?? is the density difference between the liquid and the atmosphere, g is the local gravitational acceleration, P is the pressure at the cross section of the droplet cut from a horizontal plane of the measurement point, R is the radius of a circular surface formed by cutting the droplet, ? is the inclination angle between the tangent line of the measurement point on the droplet and the horizontal plane, and V is the droplet volume at the lower part of the cross section of the droplet.
    Type: Application
    Filed: January 22, 2020
    Publication date: May 12, 2022
    Inventors: Liping YANG, Qiu ZHONG, Jun WANG, Huidong LI, Ye TAO, Wenbing WANG, Zijun XU, Caiyun LUO
  • Patent number: 11046715
    Abstract: The present disclosure relates to boronic derivatives of hydroxamate compounds, methods for making the same, methods for use as a monotherapy or in combination with one or more other therapeutic agents, for treatment of proliferative diseases such as cancer. The present disclosure also teaches the utilization of said boronic derivatives of hydroxamates as epigenetic therapy medications with enhanced bioavailability, lower-toxicity, and longer-lasting efficacy.
    Type: Grant
    Filed: November 27, 2017
    Date of Patent: June 29, 2021
    Assignee: Xavier University of Louisiana
    Inventors: Guangdi Wang, Shilong Zheng, Jiawang Liu, Qiu Zhong, Shanchun Guo
  • Patent number: 11005838
    Abstract: Systems, methods, and other embodiments associated with a monitoring process for event detection and notification transmission are described. In one embodiment, a method includes configuring a monitoring process with a matching rule used to evaluate data sources of an enterprise computing environment to determine if an event has occurred. The example method may also include executing the monitor process to identify a set of subscribers and establish a trust relationship. The example method may also include, for each subscriber, executing the monitoring process to impersonate a subscriber, execute the matching rule upon data sources accessible to the subscriber to perform a test as to whether the event has occurred, and transmit a message of the event if the event occurred.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: May 11, 2021
    Assignee: Oracle International Corporation
    Inventors: Michael Tebben, Haiyan Wang, Nicole Laurent, Qiu Zhong, Aaron Johnson, Darryl M. Shakespeare
  • Publication number: 20210133048
    Abstract: A method, computer program product, and computer system for determining, by a computing device, a weight of an indirect block page. The weight of the indirect block page may be compared to a threshold. it may be determined that the weight of the indirect block page is greater than the threshold. A copy of the indirect block page may be created as a backup page based upon, at least in part, determining that the weight of the indirect block page is greater than the threshold.
    Type: Application
    Filed: October 31, 2019
    Publication date: May 6, 2021
    Inventors: Xinlei Xu, Larry Lei Wang, Vamsi K. Vankamamidi, Ming Wang, Qiu Zhong, Alex Wang
  • Patent number: 10997040
    Abstract: A method, computer program product, and computer system for determining, by a computing device, a weight of an indirect block page. The weight of the indirect block page may be compared to a threshold. It may be determined that the weight of the indirect block page is greater than the threshold. A copy of the indirect block page may be created as a backup page based upon, at least in part, determining that the weight of the indirect block page is greater than the threshold.
    Type: Grant
    Filed: October 31, 2019
    Date of Patent: May 4, 2021
    Assignee: EMC IP Holding Company, LLC
    Inventors: Xinlei Xu, Larry Lei Wang, Vamsi K. Vankamamidi, Ming Wang, Qiu Zhong, Alex Wang
  • Publication number: 20200181175
    Abstract: The present disclosure relates to boronic derivatives of hydroxamate compounds, methods for making the same, methods for use as a monotherapy or in combination with one or more other therapeutic agents, for treatment of proliferative diseases such as cancer. The present disclosure also teaches the utilization of said boronic derivatives of hydroxamates as epigenetic therapy medications with enhanced bioavailability, lower-toxicity, and longer-lasting efficacy.
    Type: Application
    Filed: November 27, 2017
    Publication date: June 11, 2020
    Inventors: Guangdi WANG, Shilong ZHENG, Jiawang LIU, Qiu ZHONG, Shanchun GUO
  • Publication number: 20190356654
    Abstract: Systems, methods, and other embodiments associated with a monitoring process for event detection and notification transmission are described. In one embodiment, a method includes configuring a monitoring process with a matching rule used to evaluate data sources of an enterprise computing environment to determine if an event has occurred. The example method may also include executing the monitor process to identify a set of subscribers and establish a trust relationship. The example method may also include, for each subscriber, executing the monitoring process to impersonate a subscriber, execute the matching rule upon data sources accessible to the subscriber to perform a test as to whether the event has occurred, and transmit a message of the event if the event occurred.
    Type: Application
    Filed: May 15, 2018
    Publication date: November 21, 2019
    Inventors: Michael TEBBEN, Haiyan WANG, Nicole LAURENT, Qiu ZHONG, Aaron JOHNSON, Darryl M. SHAKESPEARE
  • Patent number: 10112962
    Abstract: Boron-based prodrugs of phenol- or aromatic hydroxyl group-containing therapeutic molecules (“original drugs”), uses thereof, and methods of making the same, are provided for achieving, for example, improved bioavailability, prolonged retention (e.g., in a circulatory system) and, in particular, significantly lowered therapeutically effective dosage in order to reduce adverse effects while maintaining the desired therapeutic effects of the original drugs.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: October 30, 2018
    Assignee: XAVIER UNIVERSITY
    Inventors: Guangdi Wang, Qiu Zhong, Shilong Zheng
  • Patent number: 10017475
    Abstract: Combretastatins analog compounds and their pharmaceutically acceptable salts are presented, as well as pharmaceutical compositions comprising the combretastatin analog compounds and uses of the combretastatin analog compounds, either alone or in combination with at least one additional therapeutic agent, in the treatment of cancer, and in particular cancer presenting as metastatic tumors.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: July 10, 2018
    Assignee: XAVIER UNIVERSITY OF LOUSIANA
    Inventors: Guangdi Wang, Shilong Zheng, Qiu Zhong, Qiang Zhang
  • Publication number: 20170137443
    Abstract: Boron-based prodrugs of phenol- or aromatic hydroxyl group-containing therapeutic molecules (“original drugs”), uses thereof, and methods of making the same, are provided for achieving, for example, improved bioavailability, prolonged retention (e.g., in a circulatory system) and, in particular, significantly lowered therapeutically effective dosage in order to reduce adverse effects while maintaining the desired therapeutic effects of the original drugs.
    Type: Application
    Filed: July 1, 2015
    Publication date: May 18, 2017
    Inventors: Guangdi WANG, Qiu ZHONG, Shilong ZHENG
  • Patent number: 9650369
    Abstract: Thiazole analog compounds and their pharmaceutically acceptable salts are disclosed, including pharmaceutical compositions comprising the thiazole analog compounds, either alone or in combination with at least one additional therapeutic agent, and/or with a pharmaceutically acceptable carrier. Methods of using the thiazole analog compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of cellular proliferative diseases, such as cancer, are also disclosed.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: May 16, 2017
    Assignee: XAVIER UNIVERSITY OF LOUISIANA
    Inventors: Guangdi Wang, Quan Jiang, Qiu Zhong, Qiang Zhang, Shilong Zheng
  • Patent number: 9450543
    Abstract: The present invention provides a new structure of Doherty power amplifier. The present invention reduces use of ¼ wavelength lines and lowers the Q point of the Doherty power amplifier. The present method extends the DPA bandwidth with a simpler and more convenient design and facilitates the design of a narrowed size.
    Type: Grant
    Filed: December 12, 2012
    Date of Patent: September 20, 2016
    Assignee: Alcatel Lucent
    Inventors: Yang Yang, Lintao Liu, Xianguang Guo, Kaijie Jin, Zhengde Yang, Qiu Zhong
  • Patent number: 9353132
    Abstract: The present disclosure relates to boron-based 4-hydroxytamoxifen and endoxifen prodrugs and the synthesis of the same. Further, the present disclosure teaches the utilization of the boron-based 4-hydroxytamoxifen and endoxifen prodrugs in a treatment for breast cancer.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: May 31, 2016
    Assignee: XAVIER UNIVERSITY OF LOUISIANA
    Inventors: Guangdi Wang, Shilong Zheng, Quan Jiang, Qiu Zhong, Qiang Zhang
  • Patent number: 9292613
    Abstract: Various arrangements for creating and using generic universal resource indicators are presented. To create a generic universal resource indicator, one or more parameters of a universal resource indicator may be identified. An interface that permits a parameter of the one or more parameters to be selected and mapped to a variable may be presented. A selection of the parameter for mapping may be received. An indication of the variable to map to the parameter of the selection may also be received. The generic universal resource indicator having a generic parameter corresponding to the parameter of the selection may be created.
    Type: Grant
    Filed: May 31, 2011
    Date of Patent: March 22, 2016
    Assignee: ORACLE INTERNATIONAL CORPORATION
    Inventors: Qiu Zhong, Na Li
  • Patent number: 9245044
    Abstract: Various arrangements for creating and using generic universal resource indicators are presented. To create a generic universal resource indicator, one or more parameters of a universal resource indicator may be identified. An interface that permits a parameter of the one or more parameters to be selected and mapped to a variable may be presented. A selection of the parameter for mapping may be received. An indication of the variable to map to the parameter of the selection may also be received. The generic universal resource indicator having a generic parameter corresponding to the parameter of the selection may be created.
    Type: Grant
    Filed: May 31, 2011
    Date of Patent: January 26, 2016
    Assignee: ORACLE INTERNATIONAL CORPORATION
    Inventors: Qiu Zhong, Na Li
  • Publication number: 20150274714
    Abstract: Thiazole analog compounds and their pharmaceutically acceptable salts are disclosed, including pharmaceutical compositions comprising the thiazole analog compounds, either alone or in combination with at least one additional therapeutic agent, and/or with a pharmaceutically acceptable carrier. Methods of using the thiazole analog compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of cellular proliferative diseases, such as cancer, are also disclosed.
    Type: Application
    Filed: September 27, 2013
    Publication date: October 1, 2015
    Inventors: Guangdi Wang, Quan Jiang, Qiu Zhong, Qiang Zhang, Shilong Zheng
  • Publication number: 20150080339
    Abstract: The present disclosure relates to boron-based 4-hydroxytamoxifen and endoxifen prodrugs and the synthesis of the same. Further, the present disclosure teaches the utilization of the boron-based 4-hydroxytamoxifen and endoxifen prodrugs in a treatment for breast cancer.
    Type: Application
    Filed: March 5, 2013
    Publication date: March 19, 2015
    Inventors: Guangdi Wang, Shilong Zheng, Quan Jiang, Qiu Zhong, Qiang Zhang
  • Publication number: 20140347134
    Abstract: The present invention provides a new structure of Doherty power amplifier. The present invention reduces use of ¼ wavelength lines and lowers the Q point of the Doherty power amplifier. The present method extends the DPA bandwidth with a simpler and more convenient design and facilitates the design of a narrowed size.
    Type: Application
    Filed: December 12, 2012
    Publication date: November 27, 2014
    Applicant: ALCATEL LUCENT
    Inventors: Yang Yang, Lintao Liu, Xianguang Guo, Kaijie Jin, Zhengde Yang, Qiu Zhong
  • Patent number: 8769103
    Abstract: Various arrangements for creating and using generic universal resource indicators are presented. To create a generic universal resource indicator, one or more parameters of a universal resource indicator may be identified. An interface that permits a parameter of the one or more parameters to be selected and mapped to a variable may be presented. A selection of the parameter for mapping may be received. An indication of the variable to map to the parameter of the selection may also be received. The generic universal resource indicator having a generic parameter corresponding to the parameter of the selection may be created.
    Type: Grant
    Filed: May 31, 2011
    Date of Patent: July 1, 2014
    Assignee: Oracle International Corporation
    Inventors: Qiu Zhong, Na Li